SHANGHAI, March 18 (Xinhua) -- A Chinese research team has developed a multicellular scaffold based on inorganic bioceramics for treating tendon-to-bone injuries.
Restriction of motor activity due to loss of natural structure is a major cause of decreased life quality in patients suffering from tendon-to-bone injuries.
To solve this problem, the research team, led by the Shanghai Institute of Ceramics (SIC) of the Chinese Academy of Sciences, combined manganese silicate (MS) nanoparticles with tendon/bone-related cells to construct an immunomodulatory multicellular scaffold to achieve integrated tendon-to-bone regeneration.
The scaffold not only demonstrated diverse biological activities in vitro, but also achieved immune regulation, multi-tissue integration regeneration and motor function recovery in a variety of animal models of rotator cuff injury.
The study provides a new concept for achieving immunomodulation and integrated regeneration of tendon-bone and other tissue interfaces, said Wu Chengtie with the SIC, who led the research.
The study was recently published in the journal Science Advances.
(Editor:Fu Bo)
Father rescued from migrant boat tragedy in Channel 'watched four
Xinjiang's ski resorts draw growing crowds
Chinese national among dead in Bangkok mall shooting
China adopts measures to promote recovery of inbound tourism
Election 2024: Republican candidates vying for Indiana governor to take debate stage
Prehistoric reptile fossil found in China's Three Gorges area
Winter sports become new custom of China
Chinese swimmer Wang wins men's 200m IM at Tokyo Olympics
Emily Blunt gazes adoringly at husband John Krasinski as they grace the red carpet at star
China to further improve visa policies
Rihanna camouflages herself as a TREE in a full body twig suit as she fronts FENTY x Puma campaign
Country's tourism market off to a robust start in 2024